Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





ACETONITRILE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 75-05-8; **Chemical Formula:** CH3CN
Acetonitrile is most widely used in industry as a specialty solvent and chemical intermediate. OSHA’s former occupational exposure limit for acetonitrile was a 40-ppm 8-hour TWA. The ACGIH has a 40-ppm TLV-TWA with a 60-ppm TLV-STEL, in addition to a skin notation. OSHA proposed to reduce the former 8-hour TWA PEL to 20 ppm with a skin notation; this was the NIOSH REL, and NIOSH concurred with the proposed limit (Ex. 8-47, Table N1). However, after a thorough evaluation of the record evidence, OSHA has concluded that the ACGIH limits for this substance will provide appropriate protection against acetonitrile’s systemic toxicity. Accordingly, the final rule establishes an 8-hour TWA of 40 ppm and a STEL of 60 ppm, without a skin notation, for acetonitrile.
In animal studies, acetonitrile has been found to be embryotoxic and teratogenic in rodents exposed to levels sufficiently high to cause maternal toxicity (Berteau, Levinskas, and Rodwell 1982/Ex. 1-179; Willhite 1983/ Ex. 1-43). A 13-week inhalation study conducted by the National Toxicology Program (Hazleton Laboratories, Inc. 1983, as cited in ACGIH 1986/Ex. 1-3, p. 8) found pathological changes in the liver and some blood changes in mice and rats exposed to concentrations of 400 ppm acetonitrile.
The human evidence describing the toxic effects associated with exposure to acetonitrile consists of a report by Pozzani, Carpenter, Palm et al. (1959/Ex. 1-106), who exposed human subjects to acetonitrile vapor, and a case report by Amdur (1959/Ex. 1-143), who described a poisoning incident involving acetonitrile. None of three subjects exposed to 40 ppm for four hours reported any adverse responses during the exposure period, but one subject experienced tightness of the chest a few hours after termination of exposure, as well as a cooling sensation in the lungs the following day. None of the subjects had elevated blood cyanide levels; one subject showed a slightly elevated urinary thiocyanate level. Pozzani et al. (1959/Ex. 1-106) also exposed two subjects to 80 ppm and 160 ppm of acetonitrile for four hours. When exposed to 80 ppm, subjects reported no adverse response; however, at 160 ppm, one subject experienced slight flushing of the face and chest tightness a few hours after exposure (Pozzani, Carpenter, Palm et al. 1959/Ex. 1-106).
In addition to the Pozzani et al. (1959/Ex. 1-106) study, NIOSH (1978g/Ex. 1-262) cites a report by Amdur (1959/Ex. 1-143), who investigated an incident in which 16 painters became ill (with one death) after using an acetonitrile-containing material in a confined space. Amdur (1959/Ex. 1-143) reported no further incidents after adequate ventilation was installed and acetonitrile levels were maintained at about 17 ppm. NIOSH concluded that exposure to 40 ppm may have produced minimal effects and that no observable effects were produced at 17 ppm (NIOSH 1978g/Ex. 1-262, p. 97). Therefore, NIOSH recommended that exposure not exceed 20 ppm as a 10-hour TWA. Other than the comment by NIOSH (Ex. 8-47), no comments were received on this substance.
OSHA has carefully re-evaluated the evidence of acetonitrile’s toxicity to determine the appropriate permissible exposure limits to establish in the final rule. The Agency concludes that the evidence in humans suggests that no adverse effects are experienced at long-term exposures of 40 ppm and that a short-term limit of 60 ppm will provide protection against the facial flushing and chest tightness experienced by workers exposed for several hours to levels above these concentrations. In addition, in accordance with the policy on skin notations enunciated in Section VI.C.18, OSHA is not including a skin notation for acetonitrile in the final rule (the dermal LD(50) in rabbits is 1250 mg/kg).
In the final rule, OSHA is therefore retaining its existing 8-hour TWA for acetonitrile and adding a STEL of 60 ppm to protect against this substance’s systemic effects. The Agency concludes that these limits will prevent the significant risk of acute illness (and, in one case, death) observed in workers exposed to excessive short-term exposures of acetonitrile; the Agency finds that these health effects clearly constitute material impairments of health. In the proposal, OSHA specifically requested information on the feasibility of achieving the proposed limit; no comments were received, and OSHA accordingly assumes that the final rule’s limits, which are higher than the limit proposed, are feasible.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue